Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TECNO: Intra-arterial Tenecteplase for Noncomplete Reperfusion in Ischemic Stroke
NCT05499832Phase 3Completed
- Sponsor
- Insel Gruppe
- Start
- Mar 2023
- Primary completion
- Oct 2025
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 7
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, sponsored by Insel Gruppe. Started Mar 2023; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05499832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05499832.